Melissa Susan Putman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 25 | 2024 | 1286 | 7.700 |
Why?
|
Blood Glucose Self-Monitoring | 9 | 2024 | 467 | 1.930 |
Why?
|
Bone Density | 14 | 2021 | 3551 | 1.620 |
Why?
|
Insulin Infusion Systems | 6 | 2024 | 217 | 1.580 |
Why?
|
Diabetes Mellitus | 9 | 2024 | 5840 | 1.490 |
Why?
|
Radius | 7 | 2021 | 441 | 1.430 |
Why?
|
Blood Glucose | 13 | 2024 | 6391 | 1.400 |
Why?
|
Glucose Intolerance | 2 | 2023 | 575 | 1.290 |
Why?
|
Tibia | 7 | 2016 | 1070 | 1.170 |
Why?
|
Hyperglycemia | 3 | 2024 | 1376 | 1.030 |
Why?
|
Hypoglycemia | 2 | 2024 | 884 | 1.000 |
Why?
|
Human Growth Hormone | 2 | 2021 | 638 | 0.980 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2024 | 3441 | 0.940 |
Why?
|
Aminophenols | 3 | 2022 | 87 | 0.940 |
Why?
|
Quinolones | 3 | 2022 | 378 | 0.890 |
Why?
|
Pancreas, Artificial | 2 | 2020 | 54 | 0.850 |
Why?
|
Bone Diseases | 3 | 2019 | 418 | 0.770 |
Why?
|
Absorptiometry, Photon | 8 | 2022 | 1737 | 0.750 |
Why?
|
Insulin | 6 | 2024 | 6602 | 0.740 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 5 | 2023 | 450 | 0.690 |
Why?
|
Fractures, Bone | 3 | 2018 | 2046 | 0.660 |
Why?
|
Bone and Bones | 4 | 2021 | 2568 | 0.630 |
Why?
|
Gastrointestinal Agents | 2 | 2020 | 510 | 0.630 |
Why?
|
Hypoglycemic Agents | 5 | 2024 | 3081 | 0.620 |
Why?
|
Monitoring, Ambulatory | 1 | 2020 | 354 | 0.570 |
Why?
|
Glucagon | 1 | 2019 | 532 | 0.570 |
Why?
|
Growth Disorders | 2 | 2019 | 653 | 0.560 |
Why?
|
Eating | 1 | 2022 | 1538 | 0.490 |
Why?
|
Body Composition | 3 | 2022 | 2422 | 0.480 |
Why?
|
Tibial Fractures | 1 | 2017 | 268 | 0.450 |
Why?
|
Bionics | 3 | 2024 | 46 | 0.450 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2013 | 53 | 0.420 |
Why?
|
Body Height | 1 | 2018 | 1570 | 0.400 |
Why?
|
Forearm | 1 | 2013 | 427 | 0.350 |
Why?
|
Adipose Tissue | 1 | 2022 | 3312 | 0.340 |
Why?
|
Technology | 2 | 2022 | 292 | 0.330 |
Why?
|
Lung Transplantation | 1 | 2018 | 1309 | 0.310 |
Why?
|
Adult | 21 | 2024 | 221148 | 0.290 |
Why?
|
Adolescent | 15 | 2023 | 88313 | 0.280 |
Why?
|
Exercise | 1 | 2022 | 5884 | 0.240 |
Why?
|
Humans | 47 | 2024 | 761423 | 0.240 |
Why?
|
Research | 2 | 2023 | 1977 | 0.240 |
Why?
|
Telemedicine | 2 | 2024 | 3051 | 0.230 |
Why?
|
Young Adult | 11 | 2022 | 59207 | 0.220 |
Why?
|
Vitamin D | 2 | 2019 | 3301 | 0.220 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1386 | 0.210 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 12143 | 0.200 |
Why?
|
Calibration | 1 | 2024 | 818 | 0.190 |
Why?
|
Benzodioxoles | 1 | 2021 | 75 | 0.190 |
Why?
|
Endpoint Determination | 1 | 2024 | 590 | 0.190 |
Why?
|
Case-Control Studies | 6 | 2022 | 22168 | 0.170 |
Why?
|
Advisory Committees | 1 | 2024 | 786 | 0.170 |
Why?
|
Pyrrolidines | 1 | 2021 | 338 | 0.170 |
Why?
|
Quality of Life | 4 | 2022 | 13361 | 0.160 |
Why?
|
Growth Hormone | 1 | 2021 | 569 | 0.160 |
Why?
|
Bone Diseases, Metabolic | 2 | 2019 | 409 | 0.150 |
Why?
|
Male | 20 | 2024 | 360736 | 0.150 |
Why?
|
Child | 8 | 2022 | 80162 | 0.150 |
Why?
|
Diet Surveys | 1 | 2022 | 1162 | 0.150 |
Why?
|
Female | 27 | 2024 | 392581 | 0.140 |
Why?
|
Pancreas | 1 | 2024 | 1690 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1738 | 0.130 |
Why?
|
Vital Capacity | 1 | 2018 | 970 | 0.130 |
Why?
|
Immobilization | 1 | 2016 | 229 | 0.130 |
Why?
|
Fasting | 2 | 2018 | 1602 | 0.120 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1812 | 0.110 |
Why?
|
Exercise Tolerance | 1 | 2018 | 836 | 0.110 |
Why?
|
Hypogonadism | 1 | 2019 | 798 | 0.110 |
Why?
|
Indoles | 1 | 2021 | 1832 | 0.110 |
Why?
|
Diphosphonates | 1 | 2018 | 636 | 0.110 |
Why?
|
Radiography | 1 | 2024 | 6966 | 0.110 |
Why?
|
Infertility | 1 | 2019 | 654 | 0.100 |
Why?
|
Body Mass Index | 2 | 2022 | 12951 | 0.100 |
Why?
|
Postmenopause | 1 | 2021 | 2513 | 0.100 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26112 | 0.100 |
Why?
|
Nutrition Disorders | 3 | 2000 | 205 | 0.100 |
Why?
|
Mutation, Missense | 1 | 2021 | 2571 | 0.100 |
Why?
|
Middle Aged | 11 | 2024 | 220826 | 0.090 |
Why?
|
Finite Element Analysis | 1 | 2013 | 437 | 0.090 |
Why?
|
Prospective Studies | 3 | 2024 | 54415 | 0.090 |
Why?
|
Pyrazoles | 1 | 2021 | 2007 | 0.090 |
Why?
|
Hospitals | 1 | 2024 | 3882 | 0.090 |
Why?
|
Weight-Bearing | 1 | 2013 | 532 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8000 | 0.090 |
Why?
|
Menstruation | 1 | 2012 | 307 | 0.090 |
Why?
|
Forecasting | 1 | 2019 | 2928 | 0.090 |
Why?
|
Hospitals, Pediatric | 1 | 2019 | 1862 | 0.090 |
Why?
|
Models, Animal | 1 | 2016 | 2113 | 0.090 |
Why?
|
Cohort Studies | 3 | 2021 | 41446 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1669 | 0.080 |
Why?
|
Cost of Illness | 1 | 2019 | 1936 | 0.080 |
Why?
|
Pyridines | 1 | 2021 | 2875 | 0.080 |
Why?
|
Anticonvulsants | 1 | 2019 | 1906 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20556 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6532 | 0.080 |
Why?
|
Amenorrhea | 1 | 2012 | 483 | 0.080 |
Why?
|
Body Weight | 1 | 2018 | 4618 | 0.070 |
Why?
|
Child, Preschool | 3 | 2021 | 42254 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2020 | 3744 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3460 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2015 | 818 | 0.070 |
Why?
|
Sports | 1 | 2012 | 705 | 0.070 |
Why?
|
Osteoporosis | 1 | 2015 | 1605 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10203 | 0.060 |
Why?
|
History, 20th Century | 1 | 2013 | 2769 | 0.060 |
Why?
|
Equipment Design | 1 | 2013 | 3509 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10718 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3800 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1277 | 0.060 |
Why?
|
beta-Galactosidase | 2 | 1997 | 574 | 0.060 |
Why?
|
Epilepsy | 1 | 2019 | 3290 | 0.060 |
Why?
|
Aged | 4 | 2024 | 169235 | 0.050 |
Why?
|
Infant | 4 | 2024 | 36205 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2022 | 80582 | 0.050 |
Why?
|
Lung | 1 | 2022 | 9995 | 0.050 |
Why?
|
alpha-Glucosidases | 2 | 2000 | 45 | 0.050 |
Why?
|
Periodicals as Topic | 1 | 2013 | 1463 | 0.050 |
Why?
|
Isoenzymes | 2 | 1998 | 1688 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4946 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39117 | 0.050 |
Why?
|
Medication Adherence | 1 | 2012 | 2176 | 0.050 |
Why?
|
Prevalence | 1 | 2018 | 15717 | 0.050 |
Why?
|
Endometriosis | 2 | 1999 | 869 | 0.040 |
Why?
|
Femoral Fractures | 1 | 2024 | 375 | 0.040 |
Why?
|
Lactation | 1 | 2022 | 397 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2012 | 3414 | 0.040 |
Why?
|
Boston | 1 | 2012 | 9330 | 0.040 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 1998 | 56 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2012 | 12330 | 0.040 |
Why?
|
United States | 3 | 2024 | 72339 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12938 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18400 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1703 | 0.040 |
Why?
|
Hip Fractures | 1 | 2024 | 988 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 1999 | 513 | 0.030 |
Why?
|
Lumbar Vertebrae | 2 | 2015 | 1881 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2013 | 26212 | 0.030 |
Why?
|
Porosity | 1 | 2014 | 349 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 74167 | 0.030 |
Why?
|
Jejunum | 2 | 1992 | 472 | 0.030 |
Why?
|
Hip | 1 | 2015 | 255 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 39975 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 23990 | 0.030 |
Why?
|
Enzyme Precursors | 1 | 1992 | 174 | 0.030 |
Why?
|
Estrogens | 1 | 1999 | 1522 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1997 | 1171 | 0.030 |
Why?
|
Diarrhea, Infantile | 1 | 1992 | 101 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2019 | 2426 | 0.020 |
Why?
|
Microvilli | 1 | 1992 | 234 | 0.020 |
Why?
|
Estradiol | 1 | 1998 | 1937 | 0.020 |
Why?
|
Intestines | 1 | 2000 | 1909 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2015 | 1682 | 0.020 |
Why?
|
Rabbits | 1 | 2016 | 4779 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2625 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14664 | 0.020 |
Why?
|
Intestinal Mucosa | 3 | 2000 | 3030 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3712 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9645 | 0.020 |
Why?
|
Hip Joint | 1 | 2014 | 1013 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2012 | 64651 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10498 | 0.020 |
Why?
|
Adiposity | 1 | 2015 | 1877 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13255 | 0.020 |
Why?
|
Sucrase | 2 | 1997 | 51 | 0.020 |
Why?
|
Lactase | 2 | 1997 | 71 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16606 | 0.010 |
Why?
|
Weight Loss | 1 | 2015 | 2683 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2014 | 3963 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29862 | 0.010 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2000 | 108 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2000 | 12796 | 0.010 |
Why?
|
Receptors, Estradiol | 1 | 1998 | 18 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58956 | 0.010 |
Why?
|
Aromatase | 1 | 1999 | 147 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12058 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29620 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13502 | 0.010 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2000 | 436 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1998 | 1545 | 0.010 |
Why?
|
Endometrium | 1 | 1998 | 403 | 0.010 |
Why?
|
Atrophy | 1 | 2000 | 1633 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2000 | 1134 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 1998 | 1129 | 0.010 |
Why?
|
Aging | 1 | 1992 | 8705 | 0.010 |
Why?
|
Oligo-1,6-Glucosidase | 1 | 1992 | 7 | 0.010 |
Why?
|
Actins | 1 | 2000 | 2050 | 0.010 |
Why?
|
Aminopeptidases | 1 | 1992 | 95 | 0.010 |
Why?
|
Nutritional Status | 1 | 2000 | 1613 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 4575 | 0.010 |
Why?
|
Reference Values | 1 | 1998 | 4921 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2000 | 3702 | 0.010 |
Why?
|
Thyroxine | 1 | 1992 | 668 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1992 | 2469 | 0.000 |
Why?
|
Biopsy | 1 | 2000 | 6766 | 0.000 |
Why?
|
Carrier Proteins | 1 | 2000 | 4936 | 0.000 |
Why?
|
Animals | 2 | 2016 | 168441 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1998 | 11073 | 0.000 |
Why?
|
Microscopy, Fluorescence | 1 | 1992 | 2645 | 0.000 |
Why?
|
Genotype | 1 | 1997 | 13009 | 0.000 |
Why?
|
Chronic Disease | 1 | 1992 | 9320 | 0.000 |
Why?
|
Rats | 1 | 1992 | 23742 | 0.000 |
Why?
|